Release Date: 03/07/09 14:49 Summary: Conditional Heads of Agreement Price Sensitive: Yes Download Document 162.15KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%